US
GLP-1s
GLP-1s are a new class of weight loss injections proven to help people achieve significant weight loss by reducing appetite and improving insulin function. Learn what GLP-1s are, how they work, whether you should use them, and the possible side effects.
GLP-1s
Wegovy side effects
The most common side effects of Wegovy are nausea, constipation, vomiting, and diarrhoea. Find out how to manage them in this guide.
GLP-1s
Can you switch from Wegovy to Mounjaro?
You can switch from Mounjaro to Wegovy, but you can't use them at the same time. Find out how our clinical team reviews this here.
GLP-1s
Can you switch from Ozempic to Mounjaro?
You can switch from Ozempic to Mounjaro, but you can't be on them at the same time. Find out more from our clinical team here.
GLP-1s
Can you get Mounjaro on the NHS?
Mounjaro has been approved for people living with type 2 diabetes & obesity in the UK & will be available on the NHS and from Second Nature by early 2024.
GLP-1s
What is the over-the-counter alternative to Wegovy?
Orlistat is available as an over-the-counter weight-loss medication in the UK, but it's not as effective as Wegovy. Find out more here.
GLP-1s
Semaglutide (Wegovy) to be available on the NHS
NICE has confirmed that semaglutide (Wegovy) will be available on Second Nature via the NHS when Wegovy becomes available later this year.
GLP-1s
Wegovy weight-loss jab launches in the UK
Wegovy (semaglutide) will launch in the UK from 4th September 2023. It will be available on the NHS and some private companies like Second Nature.
GLP-1s
Saxenda cost
Saxenda costs around £323.99, or around £160 per month, but you'll need a prescription - find out if you're eligible here.
As seen on
As seen on
